SunSirs: The Market of Ophiopogon Japonicus Rises by the Rnd of 2022 due to Increased Demand for Traditional Chinese Medicine!

According to the price monitoring of SunSirs, the overall market of ophiopogon japonicus in 2022 is in a volatile upward trend. At the beginning of the year, the unified price of ophiopogon japonicus was 70.50 RMB/kg. As of December 13, the average price of ophiopogon japonicus was 78.00 RMB/kg, an increase of 10.64% in the year. In the first half of the year, the price of ophiopogon japonicus showed a downward trend. The lowest point was 65.25 RMB/kg on June 24. Since August 5, the price has risen to 78.00 RMB/kg, or 19.54%. At the end of the year, driven by the increase in the price of epidemic varieties, the price of ophiopogon japonicus increased significantly, rising to 89.17 RMB/kg, the highest price in history, and the highest increase in the year was 26.48%.

In the first half of the year, the market of ophiopogon japonicus fell in shock

At the beginning of January, with the approaching of the new production period and the approaching of the Lunar New Year customs, the local merchants with large and small goods have a strong desire to ship, while the buyers at the origin are all doing business step by step, buying on demand. The movement of large goods is relatively weak, and the market is falling. The price of Sichuan Maidong unified goods has dropped 65.75 RMB/kg from 70.50 RMB/kg at the beginning of the month, a decline of 6.74%. At the beginning of March, Ophiopogon japonicus began to produce new crops. The output in Hubei and Shandong was not large. The output of Ophiopogon japonicus decreased significantly, and the price increased significantly. At the beginning of the new production, the price of Ophiopogon japonicus also increased slightly. However, in the early stage of Sichuan ophiopogon japonicus, the root erosion phenomenon occurred due to excessive rainfall, but the expected production reduction did not occur. The overall output in 2022 increased compared with that of last year, and the total output of new goods this year was not less than 11000 tons. With the influence of the inventory of old goods, the market of ophiopogon japonicus was gradually weak, and the price was basically stable.

In the second half of the year, the price of ophiopogon japonicus began to rise due to its strong reluctance to sell

After the new production of Ophiopogon japonicus, the market has been steadily digested for several months. Due to the high temperature this summer, it is estimated that the output of next year will be lower than that of last year. The supply of goods is in the hands of individual traders, who are reluctant to sell. Recently, many merchants have come to look for goods. The supply of goods moves smoothly. The price of Ophiopogon japonicus began to rise at the end of August. By the end of October, the price rose to 78 RMB/kg, or 19.54%. After the price rise, after November, the market was basically stable, and the supply of goods moved normally. The merchants of Ophiopogon japonicus, the place of origin, bought as needed, and the local sellers who were reluctant to sell during the price rise also changed their reluctance to sell. In December, driven by the price rise of epidemic varieties, a large number of pharmaceutical companies began to purchase ophiopogon japonicus in large quantities due to the increased demand for drugs due to the epidemic situation. The price rose significantly, reaching the highest price in history, 89.17 RMB/kg.

Yield of ophiopogon japonicus

Last year, the root of ophiopogon japonicus was eroded due to too much rain. Many businessmen believed that this year's yield of ophiopogon japonicus would decrease. But with the beginning of the new production, the actual grains of ophiopogon japonicus produced this year were full, and the average yield per mu was higher than the average yield per mu in 2021. Although there was a black head rate of ophiopogon japonicus seeds, the amount was not too large, and the fruit bearing rate was higher.

That is to say, although the root erosion of ophiopogon japonicus occurred in the early stage due to excessive rainfall, the expected production reduction did not occur. The overall output in 2022 will increase compared with last year, and the total output of new goods this year will not be less than 11,000 tons.

Ophiopogon japonicus inventory

At the beginning of this year, the old stock of ophiopogon japonicus was mainly concentrated in the hands of large customers. According to statistics, the current old stock in the production area is not less than 2,500 tons. In addition, it is estimated that the total old stock in each major market is not less than 500 tons, which means that the total old stock is not less than 3,000 tons.

It is estimated that the superposition of new goods output and old goods inventory will lead to the oversupply of Sichuan Maidong in 2022.

Rigid demand of Maidong Pharmaceutical Factory

Ophiopogon japonicus is a traditional bulk medicinal material in China. Because it has the effects of nourishing yin and promoting fluid production, moistening the lungs and clearing the heart, it is often used for dry cough, internal heat to quench thirst, upset insomnia, intestinal dryness and constipation. Ophiopogon japonicus is a kind of one year and two year old variety, with sufficient seedlings, so the variety resources have strong recoverability. According to statistics, the consumption of ophiopogon japonicus will be about 12,260 tons in 2020 and 12,880 tons in 2021.

In terms of demand for Chinese patent medicines, 7,702 kinds of Chinese patent medicines were screened. At present, 187 Chinese patent medicines contain ophiopogon japonicus. The top Chinese patent medicines in demand are Shexiang Baoxin Pill, Tianwang Buxin Pill, Asthma Pill, etc. The Chinese patent medicine enterprises with the highest demand of Ophiopogon japonicus are Haihehuang Pharmaceutical Co., Ltd., Guangzhou Baiyunshan Jingxiu Hall Pharmaceutical Co., Ltd., Jiangxi Sinopharm Co., Ltd., etc.

To sum up, the market of ophiopogon japonicus has risen steadily this year. At the end of the year, driven by the rising price of epidemic varieties, a large number of pharmaceutical companies began to purchase ophiopogon japonicus in large quantities due to the increased demand for drugs due to the epidemic situation. The price has risen significantly. It is almost three months before the mass production of new products. Besides, the production of new futures is not enough. SunSirs believes that the market of new ophiopogon japonicus production next year may still run high.

If you have any questions, please feel free to contact SunSirs with support@sunsirs.com.